Kathelijn Fischer
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic-guided Dosing of Emicizumab (NCT06320626) | Kathelijn Fischer | 2022-09-08 |
Track Kathelijn Fischer automatically
Every clearance here is in the API, with alerts when new ones post.